Cardiovascular Disease Doctors in Troy, OH Accepting Medicare

6 Cardiovascular Disease doctors found. Showing 1 - 6

Dr. Bryan Jenkins King, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3006 N County Road 25a Ste 104, Troy, OH 45373 Phone: 937-335-3518    Fax: 937-332-6857

Aaron J Kaibas, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3006 N County Road 25a, Suite 104, Troy, OH 45373 Phone: 937-335-3518    Fax: 937-332-6857

Dr. Suk Wan Lee, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 998 S Dorset Rd, Suite 206, Troy, OH 45373 Phone: 937-332-1165    Fax: 937-332-1384

William J Czajka, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3006 N County Road 25a, Ste 104, Troy, OH 45373 Phone: 937-335-3518    Fax: 937-332-6857

Thomas E Kupper, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 N County Road 25a, Suite 104, Troy, OH 45373 Phone: 937-335-3518    Fax: 937-332-6857

Cass M Cullis, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 N County Road 25a, Ste 104, Troy, OH 45373 Phone: 937-335-3518    Fax: 937-332-6857

News Archive

Cerapedics' i-FACTOR Peptide Enhanced Bone Graft gets FDA approval for use in cervical spine surgery

Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) application for i-FACTOR™ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft is the first bone graft to be approved for use in the cervical spine and only the second PMA-approved bone graft in the spine.

House votes to use health law prevention fund to help pay for student loan program

The Republican-led House passed legislation to prevent the U.S. student-loan interest rate from doubling on July 1, defying President Barack Obama's threat to veto the measure because it would raid a health-prevention fund to finance the subsidy. The bill to extend the subsidy for one year passed on a 215-195 vote.

PCF announces Challenge Awards to support research on new treatment strategies for prostate cancer

The Prostate Cancer Foundation (PCF) announces 3 new Challenge Awards to support discoveries for the treatment of lethal prostate cancer.

Special issue of FMCH focuses on care and disease management interventions in China, Australia

A Sino-Australian forum is the theme of the new issue of Family Medicine and Community Health (FMCH), an international medical journal with editorial offices in China and the U.S.

ImmunoGen receives FDA orphan drug designation for IMGN901 compound in treatment of MCC

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.

Read more Medical News

› Verified 1 days ago